How a new blood-clotting drug affects clotting with and without aspirin
Treatments studied
This study tests an experimental drug (BAY3389934) to see how it affects blood clotting and if it's safe. It is given to healthy adults, alone and then with aspirin. It will help researchers understand how the drug works before testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are in general good health (no major medical conditions).
- Your weight is within a healthy range (BMI 18.0 to 29.9).
- You have no increased risk of bleeding (like a bleeding disorder, frequent nosebleeds, or stomach ulcers).
- If you are male, you agree to use condoms during sex with a female partner who could become pregnant, and you won't donate sperm. If you are female, you cannot be pregnant or able to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new blood-thinning medication (CG-0255) works in the body and compares it with Plavix, a common blood thinner. Researchers will measure how much of the drug enters your bloodstream and what effects it has on your blood clotting ability.
This is an early-stage safety study testing a new experimental medicine that affects blood clotting in people with no serious health conditions. Researchers want to make sure the medicine is safe and well-tolerated before testing it in patients who need it.
This study tests how a new investigational medicine affects the way your body handles two common drugs: a blood thinner (dabigatran) and a cholesterol-lowering medicine (rosuvastatin). It helps researchers understand if the new medicine is safe to use together with these drugs.
This trial tests how a new drug, JP-1366, interacts with several common heart and blood medications (clopidogrel, aspirin, atorvastatin, and apixaban) in healthy volunteers. It aims to see if the combination is safe and how the drugs affect each other in the body.
This study tests a new drug called ASP3082 to see how the body absorbs, distributes, and removes it. It is for healthy men only and will help researchers understand the drug's behavior before it is tested in patients.
This study compares how well a diabetes drug, sotagliflozin, affects blood clotting compared to common blood thinners like aspirin and clopidogrel. It may help people at risk for heart problems find a safer or more effective treatment.
Hear when a new Drug-drug Interaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.